Proposed novel classification of circumscribed Lower-Grade Gliomas (cLGG) vs. infiltrating Lower-Grade Gliomas (iLGG): Correlations of radiological features and clinical outcomes

被引:0
|
作者
Khan, Ahsan Ali [1 ]
Khalid, Muhammad Usman [1 ]
Bajwa, Mohammad Hamza [1 ]
Urooj, Faiza [1 ]
Tahir, Izza [2 ]
Angez, Meher [2 ]
Zahid, Fahad [1 ]
Baqai, Muhammad Waqas Saeed [1 ]
Aftab, Kiran [1 ]
Ansari, Shahabuddin [3 ]
Khan, Ummul Wara [1 ]
Ahmed, Ali Azan [2 ]
Enam, Syed Ather [1 ]
机构
[1] Aga Khan Univ, Dept Surg, Karachi, Pakistan
[2] Aga Khan Univ, Med Coll, Karachi, Pakistan
[3] GIK Inst Engn Sci & Technol, Dept Comp Sci, Topi, Pakistan
关键词
Circumscribed; Infiltrating; Lower-grade; Glioma; Clinical outcomes; Radiological features; CENTRAL-NERVOUS-SYSTEM; TUMORS; MUTATIONS;
D O I
10.1016/j.wnsx.2024.100356
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Purpose: We hypothesize that lower grade gliomas (LGG) can be identified and classified into two distinct subtypes: radiologically circumscribed Lower-Grade Gliomas (cLGG) and infiltrating Lower-Grade Gliomas (iLGG) based on radiological parameters and that these two different subtypes behave differently in terms of clinical outcomes. Methods: We conducted a retrospective cohort study on surgical patients diagnosed with lower grade glioma over five years. Patient records and MRIs were reviewed, and neurosurgeons classified tumors into cLGG and iLGG groups. Results: From the 165 patients in our cohort, 30 (18.2%) patients were classified as cLGG and 135 (81.8%) patients were classified as iLGG Mean age in cLGG was 31.4 years while mean age in iLGG was 37.9 years (p = 0.004). There was significant difference in mean blood loss between cLGG and iLGG groups (270 and 411 ml respectively, p = 0.020). cLGG had a significantly higher proportion of grade II tumors (p < 0.001). The overall mean survival time for the iLGG group was 14.96 +/- 1.23 months, and 18.77 +/- 2.72 months for the cLGG group. In univariate cox regression, the survival difference between LGG groups was not significant (HR = 0.888, p = 0.581), however on multivariate regression cLGG showed a significant (aHZ = 0.443, p = 0.015) positive correlation with survival. Intense contrast enhancement (HZ = 41.468, p = 0.018), blood loss (HZ = 1.002, p = 0.049), and moderately high Ki-67 (HZ = 4.589, p = 0.032) were also significant on univariate analyses. Conclusion: cLGG and iLGG are radiologically distinct groups with separate prognoses, surgical experience, and associations.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] Identification of an epigenetic prognostic signature for patients with lower-grade gliomas
    Yu, Hai
    Zhang, Duanni
    Lian, Minxue
    CNS NEUROSCIENCE & THERAPEUTICS, 2021, 27 (04) : 470 - 483
  • [32] ZEB1 expression in Chinese lower-grade gliomas
    Huang, Xiangyan
    Bai, Harrison X.
    Yang, Li
    JOURNAL OF NEURO-ONCOLOGY, 2017, 133 (01) : 213 - 215
  • [33] Integrated Multi-Omics Maps of Lower-Grade Gliomas
    Binder, Hans
    Schmidt, Maria
    Hopp, Lydia
    Davitavyan, Suren
    Arakelyan, Arsen
    Loeffler-Wirth, Henry
    CANCERS, 2022, 14 (11)
  • [34] DNA demethylation is associated with malignant progression of lower-grade gliomas
    Nomura, Masashi
    Saito, Kuniaki
    Aihara, Koki
    Nagae, Genta
    Yamamoto, Shogo
    Tatsuno, Kenji
    Ueda, Hiroki
    Fukuda, Shiro
    Umeda, Takayoshi
    Tanaka, Shota
    Takayanagi, Shunsaku
    Otani, Ryohei
    Nejo, Takahide
    Hana, Taijun
    Takahashi, Satoshi
    Kitagawa, Yosuke
    Omata, Mayu
    Higuchi, Fumi
    Nakamura, Taishi
    Muragaki, Yoshihiro
    Narita, Yoshitaka
    Nagane, Motoo
    Nishikawa, Ryo
    Ueki, Keisuke
    Saito, Nobuhito
    Aburatani, Hiroyuki
    Mukasa, Akitake
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [35] Molecular and clinical characterization of IDH associated immune signature in lower-grade gliomas
    Qian, Zenghui
    Li, Yiming
    Fan, Xing
    Zhang, Chuanbao
    Wang, Yinyan
    Jiang, Tao
    Liu, Xing
    ONCOIMMUNOLOGY, 2018, 7 (06):
  • [36] Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas
    Qian, Zenghui
    Li, Yiming
    Fan, Xing
    Zhang, Chuanbao
    Wang, Yinyan
    Jiang, Tao
    Liu, Xing
    JOURNAL OF NEURO-ONCOLOGY, 2018, 137 (01) : 127 - 137
  • [37] Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas
    Tao, Rui
    Huang, Ruoyu
    Yang, Jingchen
    Wang, Jiangfei
    Wang, Kuanyu
    BMC CANCER, 2023, 23 (01)
  • [38] Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas
    Zenghui Qian
    Yiming Li
    Xing Fan
    Chuanbao Zhang
    Yinyan Wang
    Tao Jiang
    Xing Liu
    Journal of Neuro-Oncology, 2018, 137 : 127 - 137
  • [39] Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas
    Rui Tao
    Ruoyu Huang
    Jingchen Yang
    Jiangfei Wang
    Kuanyu Wang
    BMC Cancer, 23
  • [40] Evaluation of RANO Criteria for the Assessment of Tumor Progression for Lower-Grade Gliomas
    Raman, Fabio
    Mullen, Alexander
    Byrd, Matthew
    Bae, Sejong
    Kim, Jinsuh
    Sotoudeh, Houman
    Moron, Fanny E.
    Fathallah-Shaykh, Hassan M.
    CANCERS, 2023, 15 (13)